Here’s what you should know:
1. PBAC issued the recommendation at a meeting earlier in the year. The society wanted to curb long-term PPI use at anything other than the lowest doses.
2. The group would have continued allowing PPIs to be used if GERD patients had their diagnosis confirmed via endoscopy.
3. Physicians argued the rules were “clinically not necessary and burdensome for patients.”
4. PBAC did, however, propose changing criteria for the PPIs in question to streamlined authority status.
More articles on gastroenterology:
How Carilion Clinic’s Dr. T.K. Miller plans to grow his practice + best advice for new surgeons
Outpatient spine — Key trends and opportunities from Dr. Bobby Bhatti
3 ways patient financing improves patient satisfaction
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.